• An overview of the current understanding of bleeding and thrombosis in cirrhosis.• An
evidence-based justification for bleeding risk assessment in patients with cirrhosis before …

Hereditary genetic disorders, cancer, and infectious diseases of the liver affect millions of
people around the globe and are a major public health burden. Most contemporary …

Guidelines Committee and the sounding board of BSH. It was also placed on the members
section of the BSH website for comment. It has also been reviewed by Royal College of …

Patients with acute and chronic liver disease frequently acquire unique changes in
haemodynamic and haemostatic pathways that may result in life-threatening bleeding and …

Budd Chiari syndrome (BCS) is a diverse disease with regard to the site of obstruction, the
predisposing thrombophilic disorders and clinical presentation across the Asia-Pacific …

Abstract Background & Aims Portal vein thrombosis (PVT) in cirrhosis may lead to hepatic
decompensation and increased mortality. We aimed to investigate if decreased portal vein …

Portal vein thrombosis is an important cause of portal hypertension. PVT occurs in
association with cirrhosis or as a result of malignant invasion by hepatocellular carcinoma or …

Background In patients with noncirrhotic chronic portal vein thrombosis (PVT), the benefit of
long-term anticoagulation is unknown. We assessed the effects of rivaroxaban on the risk of …

Budd–Chiari syndrome (BCS) is an uncommon condition, caused by obstruction to hepatic
venous outflow. It is largely underdiagnosed, and a high index of suspicion is required for …

Abstract Background Budd–Chiari syndrome (BCS) is a rare disease characterized by
hepatic venous outflow tract obstruction (HVOTO). Methods Recent literature has been …